BioCentury
ARTICLE | Clinical News

Bone-forming cells: Phase IIa data

August 10, 2015 7:00 AM UTC

Data from 7 patients ages 40-85 who did not respond to anti-osteoporotic therapy in the first part of an investigator-led, open-label, Belgian Phase IIa trial showed that a single infusion of IV Preob...